|
|
|
|
 |
| March 17,
2011 | ISSUE NUMBER 191 VOL 8 |
Global
Japan Earthquake: Industry Reactions at Home and Abroad
Japanese pharma has been quick to offer donations and support in the wake of the country’s environmental disaster. The rest of the world seems to have its eye on the longer-term implications.
Featured Case Studies:
 Infosys’ SAP Life Sciences Success stories
Success stories of SAP programs for large Life Sciences companies encompassing Transformational engagements, Upgrades, Support and Compliance Management – A must read for Life Sciences companies leveraging SAP for their business success.  Read more… |
R&D Spend
The Cost of New Drug R&D: When Will the Numbers Add Up?
An ongoing debate has journalists, investment analysts, pharma companies, and economists all stating the “facts” about the cost of new drug R&D. But if the numbers and data are indisputable, why are there two opposing conclusions?
Regulatory
FDA Outlines Responses to Public Health Threats
Commissioner Margaret Hamburg stresses the importance of medical countermeasures for responding to natural and deliberate threats to public health.
Outsourcing
Raising the Outsourcing Bar
The stakes for successfully managing the outsourced relationship have never been higher, writes Patricia Van Arnum.
|
 |
|
|
 // Ora, Inc. (Andover, Mass.), an ophthalmic product development firm, announced that Larry Amdahl joined its team as Director of Clinical Operations, Dry Eye.
// Clinical research organization Kendle (Cincinnati, Ohio) has appointed Dr Martha R. Feller as Vice President and Global Head of Study Start-Up.
//
Eli Lilly & Co. (Indianapolis, In.) announced that Greg Plowman, MD, PhD, will lead Lilly's oncology research efforts as Vice President, oncology research and Senior Vice President of ImClone Systems research.
// Intellect Neurosciences (New York, NY) Chairman & CEO Dr. Daniel G. Chain was recognized as an ‘Individual of Extraordinary Abilities’ in Alzheimer's Drug Research by the US Government. |
|
|
|
|
|
|
 |
|
 |
|
 |
| Last year, Cegedim Relationship Management’s annual Aggregate Spend and Disclosure Industry survey reported that about 40% of respondents were still tracking and reporting manually or with spreadsheets. How will that change as more laws are being implemented? Participate in this year’s survey to find out: |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
